Studies suggest that TNFR1 modulates immune cell expression and enhances anti-tumor activity through NF-κB and p38 MAPK signaling cascade, regulating anti-tumor immunity, which is crucial for NSCLC development (196, 197). The gene discussed is NFKB1; the disease is neoplasm.